Skip to main content
TipRanks
Go Ultimate75% OFF

Axsome Therapeutics (19X) Q1 2026 Earnings Report

5 Followers

DE:19X Q1 2026 EPS Results

Actual EPS
-EUR 1.14
Consensus EPS
-EUR 0.77
Beat/Miss
Missed by -EUR 0.38
One Year Ago EPS
-EUR 1.11

DE:19X Q1 2026 Revenue Results

Actual Revenue
EUR 173.47M
Expected Revenue
EUR 173.21M
Beat/Miss
Beat by +EUR 261.29K
YoY Revenue Growth
+57.42%

Earnings Announcement Details

Quarter
Q1 2026
Date
05/04/2026
Time
Before Open
Conference Call
Monday, May 4, 2026
DE:19X Upcoming Earnings

Axsome Therapeutics's next earnings date is estimated for March 1, 2027, based on past reporting schedules.

Q1 2026 Earnings Call Audio

DE:19X Q1 2026 Earnings Call
0:00 / 0:00

Q1 2026 Earnings Slide Deck

Q1 2026 Earnings Call Summary

No earnings call summary is available for this earnings event.

DE:19X Earnings History

DE:19X earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Mar 01, 20272026 (Q4)-0.05--0.51――
Nov 02, 20262026 (Q3)-0.58-0.23-0.8573.40% (+0.63)
Aug 10, 20262026 (Q2)-0.81-0.90-0.88-2.06% (-0.02)
May 04, 20262026 (Q1)-0.77-1.14-1.11-3.28% (-0.04)
Feb 23, 20262025 (Q4)-0.63-0.51-1.463.64% (+0.89)
Nov 03, 20252025 (Q3)-0.78-0.85-1.2229.85% (+0.36)
Aug 04, 20252025 (Q2)-0.96-0.88-1.5241.92% (+0.64)
May 05, 20252025 (Q1)-1.23-1.11-1.3115.28% (+0.20)
Feb 18, 20252024 (Q4)-0.91-1.40-1.8925.96% (+0.49)
Nov 12, 20242024 (Q3)-1.25-1.22-1.2-1.52% (-0.02)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed